CannLabs, Inc.
CANL · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $4,391 | $3,181 | $2,765 | $2,499 |
| % Growth | 38% | 15% | 10.7% | – |
| Cost of Goods Sold | $2,329 | $1,483 | $1,519 | $1,052 |
| Gross Profit | $2,063 | $1,698 | $1,246 | $1,447 |
| % Margin | 47% | 53.4% | 45.1% | 57.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,190 | $984 | $724 | $642 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,190 | $984 | $724 | $642 |
| Operating Income | $872 | $714 | $522 | $804 |
| % Margin | 19.9% | 22.5% | 18.9% | 32.2% |
| Other Income/Exp. Net | -$3 | -$2 | -$2 | -$1 |
| Pre-Tax Income | $869 | $713 | $521 | $804 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $869 | $713 | $521 | $804 |
| % Margin | 19.8% | 22.4% | 18.8% | 32.2% |
| EPS | 0.001 | 0.001 | 0.001 | 0.013 |
| % Growth | 22.2% | -18.2% | -91.5% | – |
| EPS Diluted | 0.001 | 0.001 | 0.001 | 0.013 |
| Weighted Avg Shares Out | 813,165 | 813,165 | 463,165 | 62,165 |
| Weighted Avg Shares Out Dil | 813,165 | 813,165 | 463,165 | 62,165 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $2 | $2 | $1 |
| Depreciation & Amortization | $8 | $8 | $9 | $6 |
| EBITDA | $881 | $723 | $531 | $811 |
| % Margin | 20.1% | 22.7% | 19.2% | 32.4% |